The theoretical risk of over-activating the GH-IGF-1 axis, including acromegalic side effects and proliferative signaling, is additive
Medical Supervision and Microdosing Beverly Tchang, MD, an endocrinologist and obesity specialist at NewYork-Presbyterian and Weill Cornell Medicine in New York City, instructs some of her patients to microdose to help balance side effects with weight loss goals
Think of it like beakers of water
This gatekeeping creates a two-tier system where only insured individuals in specific income brackets can afford treatment
If you reviewed and managed three diabetes complications at one visit, that drives a High MDM level
Clinical Considerations and Future Outlook For the clinician, these emerging therapies signal a move toward highly personalised obesity medicine